Cargando…
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients
BACKGROUND: Alterations in gene expression in peripheral blood cells have been shown to be sensitive to the presence and extent of coronary artery disease (CAD). A non-invasive blood test that could reliably assess obstructive CAD likelihood would have diagnostic utility. RESULTS: Microarray analysi...
Autores principales: | Elashoff, Michael R, Wingrove, James A, Beineke, Philip, Daniels, Susan E, Tingley, Whittemore G, Rosenberg, Steven, Voros, Szilard, Kraus, William E, Ginsburg, Geoffrey S, Schwartz, Robert S, Ellis, Stephen G, Tahirkheli, Naheem, Waksman, Ron, McPherson, John, Lansky, Alexandra J, Topol, Eric J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072303/ https://www.ncbi.nlm.nih.gov/pubmed/21443790 http://dx.doi.org/10.1186/1755-8794-4-26 |
Ejemplares similares
-
Whole Blood Gene Expression Testing for Coronary Artery Disease in Nondiabetic Patients: Major Adverse Cardiovascular Events and Interventions in the PREDICT Trial
por: Rosenberg, Steven, et al.
Publicado: (2012) -
A whole blood gene expression-based signature for smoking status
por: Beineke, Philip, et al.
Publicado: (2012) -
Biological and Analytical Stability of a Peripheral Blood Gene Expression Score for Obstructive Coronary Artery Disease in the PREDICT and COMPASS Studies
por: Daniels, Susan E., et al.
Publicado: (2014) -
Identification of Factors Contributing to Variability in a Blood-Based Gene Expression Test
por: Elashoff, Michael R., et al.
Publicado: (2012) -
Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit
por: Meller, Stephanie M, et al.
Publicado: (2013)